Physability

07/11/2025

Works very well with individuals who are affected by incomplete sci injuries and who can walk short distances. Also might be useful for individuals affected by stroke injury with ambulatory potential

04/11/2025

At least some robotics will be available to assist some individuals with limited gait abilities. And as it’s not focused on the paralysed population the costs are considerably less. Hip assisted robotics too are becoming very accessible

03/11/2025

27/10/2025

Good to meet Colin from Max wheel chairs , excellent service above and beyond. Even sorted out the clients chair for the better whilst visiting Physability

Everyday lightweight manual rigid and folding wheelchairs in a range of stunning colours, frame types and materials. Provided by Progeo and Per4max wheelchairs. Free home demonstration and assessment in the UK. Rigid Fixed, Rigid Adjustable or Folding Wheelchair... Which is right for you? Unsure? Cl...

22/10/2025

https://www.facebook.com/share/17881KvG6S/?mibextid=wwXIfr

The 2025 Nobel Prize in Physiology or Medicine has been awarded to scientists who made a groundbreaking discovery about regulatory T-cells, the immune system’s “peacekeepers.” Their research revealed how these cells prevent the immune system from attacking the body’s own tissues, a process crucial for preventing autoimmune diseases like type 1 diabetes, rheumatoid arthritis, and multiple sclerosis.

Regulatory T-cells maintain immune balance, ensuring the body can fight infections without turning against itself. Understanding how to control and enhance these cells opens new possibilities for therapies that treat autoimmune disorders, reduce transplant rejection, and improve overall immune regulation.

This discovery marks a major milestone in immunology, offering hope for millions affected by immune-related conditions. It also highlights the incredible precision of the human immune system and the potential of science to harness it for life-saving therapies. The work of these Nobel laureates demonstrates how targeting the body’s own regulatory mechanisms can revolutionize medicine.

17/10/2025

Some cool machines

https://www.facebook.com/share/1BCStJvkGi/?mibextid=wwXIfr

Exotek aim to bring nature and people back together by unrivaled 4WD electric mobility-vehicles!

16/10/2025

https://m.facebook.com/story.php?story_fbid=1240309774798732&id=100064591636181

15/09/2025

https://www.facebook.com/share/v/16z6ckN6vq/?mibextid=wwXIfr

15/09/2025

https://www.facebook.com/share/1K4WRNJcrx/?mibextid=wwXIfr

To protect your loved ones

21/08/2025

https://www.facebook.com/share/p/1S1UsAXHKw/?mibextid=wwXIfr

Listen to our NEW Access All Areas podcast on all things travelling with confidence on YouTube Music! 🎙️

In episode 3 our host Ollie Thorn, chats to Andy, Gyn, Lady Marie, and Victoria about everyday travel. We will hear about lived experience from our members with spinal cord injury as they discuss their experiences using the car and public transport and talk about what they prefer to use, managing unexpected challenges and resources they use to make planning easier.

This is the third episode of our 5 part series, available now on YouTube Music https://music.youtube.com/playlist?list=PLdtrijYFcd2Gz3cPG7CsQo8tzgqK4rqk6&feature=shared and our brand new online Accessible Travel Hub https://www.spinal.co.uk/twc-resource-hub/podcasts/

Funded by the Motability Foundation.

15/08/2025

Medscape medical news

Common Painkiller Tied to Heart Failure Risk in Older Adults
Megan Brooks
August 07, 2025

The antiseizure medication pregabalin, which is commonly prescribed for chronic pain, has been linked to an increased risk for heart failure (HF), particularly in those with a history of cardiovascular disease (CVD), new data suggested.

In a cohort of more than 240,000 Medicare beneficiaries with noncancer chronic pain, initiation of pregabalin was associated with a 48% higher risk for new-onset HF overall and an 85% higher risk in those with a history of CVD than initiation of gabapentin.

The study was published online on August 1 in JAMA Network Open.